Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MED17 |
| Upstream (Parents) |
|---|
| (<<) RBM7 → MED17 |
| (<<) FDX1 → MED17 |
| (<<) HAT1 → MED17 |
| (<<) CHMP2B → MED17 |
| Downstream (Children) |
|---|
| MED17 → FLJ14100 (>>) |
| MED17 → RBM7 (>>) |
| MED17 → PTPRO (>>) |
| MED17 → PSPH (>>) |
| MED17 → LILRA2 (>>) |
| MED17 → BTBD18 (>>) |
| MED17 → FLJ21369 (>>) |
| MED17 → MRE11A (>>) |
| MED17 → CYP2A13 (>>) |
| MED17 → AFP (>>) |
| MED17 → FDX1 (>>) |
| MED17 → HINFP (>>) |
| MED17 → KIAA0174 (>>) |
| MED17 → CUBN (>>) |
| MED17 → INTS7 (>>) |
| MED17 → PRAMEF10 (>>) |
